Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib

A patient with non‐small cell lung cancer (NSCLC) exhibited extreme hyperglycemia after lorlatinib treatment. The present case highlights the importance of glucose monitoring during lorlatinib administration and intensifying hyperglycemia treatment.

Detalles Bibliográficos
Autores principales: Nakano, Yoshio, Miyasato‐Isoda, Mai, Gohma, Iwao, Fujisawa, Tomomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777166/
https://www.ncbi.nlm.nih.gov/pubmed/35079389
http://dx.doi.org/10.1002/ccr3.5283
_version_ 1784637005068500992
author Nakano, Yoshio
Miyasato‐Isoda, Mai
Gohma, Iwao
Fujisawa, Tomomi
author_facet Nakano, Yoshio
Miyasato‐Isoda, Mai
Gohma, Iwao
Fujisawa, Tomomi
author_sort Nakano, Yoshio
collection PubMed
description A patient with non‐small cell lung cancer (NSCLC) exhibited extreme hyperglycemia after lorlatinib treatment. The present case highlights the importance of glucose monitoring during lorlatinib administration and intensifying hyperglycemia treatment.
format Online
Article
Text
id pubmed-8777166
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87771662022-01-24 Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib Nakano, Yoshio Miyasato‐Isoda, Mai Gohma, Iwao Fujisawa, Tomomi Clin Case Rep Case Reports A patient with non‐small cell lung cancer (NSCLC) exhibited extreme hyperglycemia after lorlatinib treatment. The present case highlights the importance of glucose monitoring during lorlatinib administration and intensifying hyperglycemia treatment. John Wiley and Sons Inc. 2022-01-20 /pmc/articles/PMC8777166/ /pubmed/35079389 http://dx.doi.org/10.1002/ccr3.5283 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Nakano, Yoshio
Miyasato‐Isoda, Mai
Gohma, Iwao
Fujisawa, Tomomi
Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
title Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
title_full Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
title_fullStr Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
title_full_unstemmed Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
title_short Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
title_sort acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777166/
https://www.ncbi.nlm.nih.gov/pubmed/35079389
http://dx.doi.org/10.1002/ccr3.5283
work_keys_str_mv AT nakanoyoshio acuteworseningofglycemiccontrolinapatientwithtype2diabetesandnonsmallcelllungcancerafteradministrationoflorlatinib
AT miyasatoisodamai acuteworseningofglycemiccontrolinapatientwithtype2diabetesandnonsmallcelllungcancerafteradministrationoflorlatinib
AT gohmaiwao acuteworseningofglycemiccontrolinapatientwithtype2diabetesandnonsmallcelllungcancerafteradministrationoflorlatinib
AT fujisawatomomi acuteworseningofglycemiccontrolinapatientwithtype2diabetesandnonsmallcelllungcancerafteradministrationoflorlatinib

Ejemplares similares